default author photo

Sunghoon Kim

Yonsei University - College of Medicine

Seoul

Korea, Republic of (South Korea)

  • Yonsei University - College of Medicine

SCHOLARLY PAPERS

3

DOWNLOADS

145

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

GX-188E DNA Vaccine Plus Pembrolizumab as a 2nd Line Treatment for HPV 16- and/or 18-Positive, PD-L1 All-Comer Recurrent or Advanced Cervical Cancer: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

Number of pages: 32 Posted: 02 Jan 2024
Myong Cheol Lim, Myong Cheol Lim, Youn Jin Choi, Soo-Young Hur, Yong-Man Kim, Jae Hong No, Byoung-Gie Kim, Chi Heum Cho, Sunghoon Kim, Dae Hoon Jeong, Jae-Kwan Lee, Ji Hyun Kim, Yoon-Jeong Choi, Jung Won Woo, Young Chul Sung and Jong Sup Park
Chinese Academy of Medical Sciences - Center for Gynecologic CancerNational Cancer Center, Korea - Center for Gynecologic Cancer, Catholic University of Korea, Catholic University of Korea, University of Ulsan - Asan Medical Center, Seoul National University - Seoul National University Bundang Hospital, Sungkyunkwan University - Samsung Medical Center, Keimyung University Dongsan Medical Center, Yonsei University - College of Medicine, Inje University, Korea University, Chinese Academy of Medical Sciences - Center for Gynecologic Cancer, Genexine, Inc., Genexine, Inc., Pohang University of Science and Technology (POSTECH) and Catholic University of Korea
Downloads 95 (720,278)

Abstract:

Loading...

2.

Efficacy of Chemotherapy Following Prior Parp-Inhibitor Treatment in Patients with Ovarian Cancer

Number of pages: 26 Posted: 19 Jun 2024
Jung Chul Kim, Jung-Yun Lee, Junsik Park, Yong Jae Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, Se Ik Kim, Jae-Weon Kim and Byoung-Gie Kim
affiliation not provided to SSRN, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - College of Medicine, affiliation not provided to SSRN, Yonsei University - Gangnam Severance Hospital, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - College of Medicine, Yonsei University, Seoul National University - Department of Obstetrics and Gynecology, Seoul National University - Seoul National University Hospital and Sungkyunkwan University - Samsung Medical Center
Downloads 30 (1,318,317)

Abstract:

Loading...

Ovarian cancer, PARP inhibitor, Prognosis, recurrence, Survival

3.

Stereotactic Ablative Body Radiotherapy May Enhance Outcomes in Oligometastatic Uterine Cervical Cancer

Number of pages: 20 Posted: 17 Apr 2025
Yong Bae Kim, Sangjoon Park, Yong Jae Lee, Min Whan Kim, Gun Min Kim, Jung-Yun Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim and Young Tae Kim
Yonsei University - Department of Radiation Oncology, Yonsei University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - Gangnam Severance Hospital, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - College of Medicine and Yonsei University
Downloads 20 (1,448,301)

Abstract:

Loading...

Uterine Cervical Neoplasms, Oligometastasis, Stereotactic Ablative Body Radiotherapy, Programmed Cell Death Ligand 1